Abstract:Alzheimer's disease (AD) has become a global threat to the elderly health with a short survival time after diagnosis. Due to the asymptomatic stage during the early development, patients are usually diagnosed at the middle or late stage. Therefore, an efficient tool for AD early diagnosis deserves considerable attention, which could make a significant contribution to the treatment intervention. A fluorescent probe has been widely applied for detecting and visualizing species of interest in vitro and in vivo, and the proper reaction between the probe and analytes is responsible for the fluorescence change to provide a lighting-on or ratiometric responsive pattern with satisfactory sensing behavior. In this work, we report the first attempt to build up an AND-logic probe P2 for AD accuracy diagnosis taking butyrylcholinesterase (BChE) and reactive oxygen species (ROSs) as dual targets. Upon the co-stimulation by these two factors through enzymatic hydrolysis and redox reaction, the NIR emission could be readily turned on. This AND sensing pattern avoided the false-positive response effectively, and other diseases sharing one biomarker could hardly induce a NIR fluorescence response. The sensing assay has also been confirmed to be feasible in vitro and in vivo with good sensibility and selectivity. It is worth mentioning that the probe structure has been optimized in terms of the linkage length. This study shows that probe P2 with a connecting arm of medium length (one methylene, n = 1) has superior sensing performance, promising to provide a reference for the relative structure design.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c02943.Experimental section, 1H, 13C NMR, and HR-MS spectral copies of synthesized compounds (Figures S1–S13), fluorescence, and HR-MS spectral profiles (Figures S14–S25), cell cytotoxicity of P1–P3 (Figure S26), spectra of P4 toward ROSs (Figure S27), and living cell imaging of probe P4 (Figure S28) and in vivo imaging (Figure S29) (PDF)This article has not yet been cited by other publications.

An Activatable Near-Infrared Fluorescent Probe with Large Stokes Shift for Visualizing Peroxynitrite in Alzheimer’s Disease Models

An activatable near-infrared fluorescent probe with large Stokes shift for visualizing peroxynitrite in Alzheimer's disease models

An Activity-Based Sensing Fluorescent Probe for Monitoring Endogenous Peroxynitrite in Alzheimer's Disease Models

An Activity-Based Fluorescent Probe for Imaging Fluctuations of Peroxynitrite (ONOO-) in the Alzheimer's Disease Brain.

Oxalate-curcumin-based probe for micro- and macroimaging of reactive oxygen species in Alzheimer's disease

A Large Stokes Shift NIR Fluorescent Probe for Visual Monitoring of Mitochondrial Peroxynitrite During Inflammation and Ferroptosis and in an Alzheimer's Disease Model.

A near-infrared fluorescent probe with remarkably large stokes shift for specifical imaging of peroxynitrite fluctuations in Hela cells

Two-photon fluorescence imaging of the cerebral peroxynitrite stress in Alzheimer's disease

Development of Near-Infrared Fluorescent Probes for Use in Alzheimer’s Disease Diagnosis

Development of Near-Infrared Fluorescent Probes for Use in Alzheimers Disease Diagnosis

Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease

Design of an Activatable NIR-II Nanoprobe for the in Vivo Elucidation of Alzheimer's Disease-Related Variations in Methylglyoxal Concentrations.

A novel NIR fluorescent probe for visualizing hydrogen sulfide in Alzheimer's disease

An Activatable Near-Infrared Fluorescent Probe for Methylglyoxal Imaging in Alzheimer's Disease Mice

Dual-Channel Imaging of Amyloid-β Plaques and Peroxynitrite to Illuminate Their Correlations in Alzheimer’s Disease Using a Unimolecular Two-Photon Fluorescent Probe

Rational Design of Quinoxalinone-Based Red-Emitting Probes for High-Affinity and Long-Term Visualizing Amyloid-β In Vivo

AND-Logic Strategy for Accurate Analysis of Alzheimer’s Disease via Fluorescent Probe Lighted Up by Two Specific Biomarkers

A novel H2O2-activated NIR fluorescent probe for imaging β-amyloid fibrils and mitochondrial viscosity

Gasotransmitter nitric oxide imaging in Alzheimer's disease and glioblastoma with diamino-cyclic-metalloiridium phosphorescence probes

Imaging Hydrogen Peroxide in Alzheimer'S Disease Via Cascade Signal Amplification

A near-infrared fluorescent probe for ratiometric imaging peroxynitrite in Parkinson's disease modelY